Drug interactions
Dolutegravir + Lovotibeglogene autotemcel
Severity: Major
Dolutegravir and Lovotibeglogene autotemcel: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Antiretrovirals can interfere with lentiviral vector transduction in manufacturing of this gene therapy. Dolutegravir exposure around apheresis may compromise product quality.
What this interaction means in plain words
Dolutegravir and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Antiretroviral activity inhibits lentiviral vector integration in collected stem cells.
What to do
Discontinue dolutegravir at least one month before mobilization and through all apheresis cycles. Coordinate an interim HIV strategy with the treating team.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dolutegravir and Lovotibeglogene autotemcel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dolutegravir
Frequently asked questions
Can I take Dolutegravir with Lovotibeglogene autotemcel?
MediHelp rates the interaction as major. Dolutegravir and Lovotibeglogene autotemcel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Antiretrovirals can interfere with lentiviral vector transduction in manufacturing of this gene therapy. Dolutegravir exposure around apheresis may compromise product quality.
How serious is the interaction between Dolutegravir and Lovotibeglogene autotemcel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Discontinue dolutegravir at least one month before mobilization and through all apheresis cycles. Coordinate an interim HIV strategy with the treating team.
What other medicines interact with Dolutegravir?
MediHelp also lists interactions of Dolutegravir with, for example, Dofetilide, Aluminum hydroxide, Atidarsagene autotemcel. The full list is on the Dolutegravir page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
